Life Biosciences Fda Clearance Er 100 Epigenetic Reprogramming Optic Neuropathy 2026

1 article on ObjectWire

ScienceMarch 3, 2026

Life Biosciences FDA Clearance: ER-100 Epigenetic Reprogramming Trial for Glaucoma & NAION — January 2026

The FDA cleared Life Biosciences

By ObjectWire Editorial